The big-time BARDA contracts keep rolling in, this time for infectious disease biotech and Merck partner ModeX Therapeutics. The company has hauled in a $168 million contract from the Biomedical ...
Opko Health Inc. (NASDAQ:OPK) is one of the best stocks under $5 with highest upside potential. ModeX Therapeutics Inc., an Opko Health Inc. (NASDAQ:OPK) company, announced on October 29 a license and ...
(RTTNews) - Wednesday, Regeneron Pharmaceuticals, Inc. (REGN) and ModeX Therapeutics Inc., an OPKO Health company (OPK) entered into a license and collaboration agreement to discover and develop ...
WESTON, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health company (NASDAQ: OPK), today announced that it has entered into a license and collaboration agreement with ...
Every industry has its must-attend event—the one gathering that sets the tone for innovation, networking, and strategy for the year ahead. For the supply chain, that event is MODEX, and for good ...
ModeX Therapeutics Inc., an OPKO Health company, announced the formation of a Scientific Advisory Board to support the development of its immunology and oncology pipeline, which includes ...
WESTON, Mass. - ModeX Therapeutics Inc., a subsidiary of OPKO Health, Inc. (NASDAQ: OPK), has received an additional $35 million in funding from the Biomedical Advanced Research and Development ...
With a modest $7 million up front but an ultimate payout potentially topping $1 billion on the line, Modex Therapeutics Inc. will collaborate with Regeneron Pharmaceuticals Inc. to find and develop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results